It’s easy to spot motivated and engaged employees. They are more productive, they go the extra mile, and they display a sense of ownership in their work.But how do you replicate this culture throughout your organization? How do you encourage…
HOME > BUSINESS
BUSINESS
- Xtandi Gets CHMP Backing for Additional CRPC Indication
September 26, 2018
- DS-8201 Shows Positive PI Study Data for NSCLC: Daiichi Sankyo
September 26, 2018
- European Panel Backs Approval of Kyowa Kirin’s Mogamulizumab for Mycosis Fungoides, Sézary Syndrome
September 26, 2018
- Santen Files for Japan Approval of Anti-Allergy Eye Drop
September 26, 2018
- Daiichi Sankyo, Pfizer Grab Japan Approval for Herceptin Biosimilars
September 25, 2018
- AMED Backs Project for Development of Familial Adenomatous Polyposis Therapy Applied by FunPep, 3 Universities
September 25, 2018
- Fujifilm Kyowa Kirin, Mylan Bag EU Approval of Humira Biosimilar
September 25, 2018
- Daiichi Sankyo Teams Up with US Merck’s Subsidiary for Clinical Research of DS-8201/Keytruda Combo
September 25, 2018
- Astellas to Create New Business beyond Core Prescription Drug Business, Aims to Launch Several Products by FY2020
September 21, 2018
- Meiji Seika Pharma Commences Shipment of KM Biologics’ Flu Vaccine
September 21, 2018
- Roxadustat Hit Goal in CKD Patients with Anemia Not on Dialysis in Multinational PIII Study: Astellas
September 21, 2018
- Meiji Files Aricept Generic for Lewy Body Dementia to Win Full Indications
September 21, 2018
- Growing Number of Drug Makers Introducing LGBT-Friendly Policies
September 20, 2018
- Sosei, Allergan Suspend Joint Clinical Development of AD Therapy due to Unexpected Toxicology Findings
September 20, 2018
- Otsuka Pharmaceutical Factory Accuses AY Pharmaceuticals, Yoshindo for Patent Infringement on Transfusion Product
September 20, 2018
- Ono, US Bioventure Fate Therapeutics Hook Up for CAR-T Therapies
September 19, 2018
- Nichi-Iko to Copromote 5 Elmed Eisai Products from October
September 18, 2018
- Astellas Joins Hands with Gene Therapy Biotech for ALS Treatment Program
September 18, 2018
- Takeda Gets China OK for Shire Takeover
September 18, 2018
- Sekisui Chemical Hooks Up with Regenerative Medicine Upstart
September 14, 2018
ページ
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…